Dramatic changes in glycolipid metabolism associated with oncogenic transformation implicate a specific role for membrane glycolipids in regulation of cell growth and cellular recognition. These changes give rise to tumor specific membrane antigens which are useful diagnostically and as potential targets for immunotherapy. Although many examples of these tumor antigens have been documented, not much information is available relating to the mechanism of regulation of biosynthesis which prevents expression of these carbohydrate structures in normal cells and tissues and is activated to produce them in association with oncogenesis. A variety of lacto-series based carbohydrate antigens have been described to occur in human colonic adenocarcinomas. Recent evidence has shown that activation of a normally unexpressed beta1->3N-acetyl- glucosaminyltransferase required for lacto-series chain synthesis coupled with activation of type 2 chain synthesis via regulation of enzyme function in Golgi membranes occurs in colonic epithelial cells and results in accumulation of these antigens. This application proposes to continue studies of this system by detailed study of enzyme regulation directing core chain synthesis associated with formation of a variety of end-stage structures which occur in these tumors. The beta1- >3galactosyltransferase which defines the type 1 chain structure and the beta1->3N-acetylglucosaminyltransferase which is activated in association with oncogenesis will be extensively studied. Utilizing expression cloning of cDNA containing plasmids via antibody-cell surface carbohydrate selection procedures, cDNA encoding the enzymes will be isolated and sequenced. Based on this information and enzyme derived from classical purification or gene expression procedures, studies will be conducted to define the nature of the transferases via active site studies and monoclonal antibody production and analysis. Studies will continue concerning the basis for relative synthesis of type 1 or 2 chain structures in normal mucosa and adenocarcinoma tumors building on present findings of the participation of membrane organization in this process. These studies will provide important information relating to the genetic and epigenetic regulation of enzymes associated with lacto-series core chains during development and oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA041521-09
Application #
2090478
Study Section
Pathology B Study Section (PTHB)
Project Start
1986-01-07
Project End
1995-12-31
Budget Start
1995-03-31
Budget End
1995-12-31
Support Year
9
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Pacific Northwest Research Institute
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98122
Schwientek, T; Almeida, R; Levery, S B et al. (1998) Cloning of a novel member of the UDP-galactose:beta-N-acetylglucosamine beta1,4-galactosyltransferase family, beta4Gal-T4, involved in glycosphingolipid biosynthesis. J Biol Chem 273:29331-40
Amado, M; Almeida, R; Carneiro, F et al. (1998) A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem 273:12770-8
Holmes, E H; Xu, Z; Sherwood, A L et al. (1995) Structure-function analysis of human alpha 1-->3fucosyltransferases. A GDP-fucose-protected, N-ethylmaleimide-sensitive site in FucT-III and FucT-V corresponds to Ser178 in FucT-IV. J Biol Chem 270:8145-51
Hu, J; Stults, C L; Holmes, E H et al. (1994) Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: differential expression in human leukaemia cells. Glycobiology 4:251-7
Meldgaard, P; Holmes, E H; Bennett, E P et al. (1994) Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization. Cancer Res 54:2440-7
Holmes, E H; Macher, B A (1993) Specificity of fucose transfer to GlcNAc residues of extended chain neolacto-series glycolipids catalyzed by human alpha 1-->3fucosyltransferases: effect of the lipidic environment on the myeloid enzyme form. Arch Biochem Biophys 301:190-9
Holmes, E H (1993) Human Lewis alpha 1-->3/4fucosyltransferase: specificity of fucose transfer to GlcNAc beta 1-->3Gal beta 1-->4Glc beta 1-->1Cer (LcOse3Cer). Glycobiology 3:77-81
Holmes, E H; Greene, T G (1993) De novo synthesis of type 1 lacto-series glycolipids in human colonic adenocarcinoma cells: efficient synthesis of the Le(a) antigen and absence of brefeldin A-induced inhibition of its synthesis in Colo 205 cells. Arch Biochem Biophys 305:328-40
Symington, F W; Holmes, E H; Symington, B E (1992) Human epidermal keratinocyte expression of sialyl-Lewis X. J Invest Dermatol 99:601-7
Sherwood, A L; Greene, T G; Holmes, E H (1992) Stable expression of a cDNA encoding a human beta 1 --> 3galactosyltransferase responsible for lacto-series type 1 core chain synthesis in non-expressing cells: variation in the nature of cell surface antigens expressed. J Cell Biochem 50:165-77

Showing the most recent 10 out of 26 publications